Neuroleptanalgesia in acute myocardial infarction: effects of hemodynamic parameters and plasma catecholamines. 1981

D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler

The use of neuroleptanalgesia in acute myocardial infarction offers the possibility of reducing pain and emotional stress. The influence of such treatment on hemodynamic parameters (heart rate, cardiac output, stroke volume, peripheral resistance, systemic blood pressure, and pulmonary pressure) and on the plasma level of adrenaline and noradrenaline has been studied in 6 patients with acute myocardial infarction. This results demonstrate that during neuroleptanalgesia the already elevated levels of noradrenaline and adrenaline further increase. This increase was most pronounced in the patients with the highest initial levels of catecholamines. Since the peripheral resistance and systolic and diastolic blood pressures decrease concomitantly, it is concluded that the increase in levels of noradrenaline and adrenaline further increase. This increase was most pronounced in the plasma catecholamines is due to a reaction of the sympathetic nervous system to the alpha-adrenergic receptor blocking activity of droperidol causing vasodilation. The data indicate that pain, emotional stress, and anxiety in the acute phase of myocardial infarction do not play the expected essential role for the activation of the sympathetic nervous system generally observed in acute myocardial infarction. Additionally, the data demonstrate that drugs producing a vasodilation can have a deteriorating effect on the hemodynamic situation and that a reduction of the afterload by vasodilating drugs can result in a further increase in the release of catecholamines.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009458 Neuroleptanalgesia A form of analgesia accompanied by general quiescence and psychic indifference to environmental stimuli, without loss of consciousness, and produced by the combined administration of a major tranquilizer (neuroleptic) and a narcotic. Neuroleptoanalgesia
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
November 1979, American heart journal,
D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
June 1984, Texas Heart Institute journal,
D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
January 1973, The Medical clinics of North America,
D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
January 1986, Acta cardiologica,
D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
January 1979, Indian heart journal,
D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
January 1969, Israel journal of medical sciences,
D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
January 1974, Circulation,
D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
December 1982, American heart journal,
D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
May 1981, Japanese circulation journal,
D Magometschnigg, and H Hörtnagl, and A Gassner, and A F Hammerle, and G Kleinberger, and R Lenzhofer, and H Lochs, and H Pall, and M Pichler
March 1985, Revista medica de Chile,
Copied contents to your clipboard!